Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00966823 · ClinicalTrials.gov registry record · Phase 2
Fetal Tracheal Balloon Study in Diaphragmatic Hernia
A Phase 2 study, sponsored by Rhode Island Hospital.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT00966823: Clinical Trial Phase 2 study, sponsored by Rhode Island Hospital.
NCT00966823 is a Phase 2 study that was terminated before completion, run by Rhode Island Hospital. The registered enrollment target is 3 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00966823, a Phase 2 study, was terminated before completion, sponsored by Rhode Island Hospital.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this phase 2 limited study is to examine whether prenatal intervention correct the lung underdevelopment associated with severe diaphragmatic hernia.
Interventions
- DEVICE Fetal tracheal obstruction with detachable balloon (device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-09 |
| Est. Completion | 2015-01 |
| Phase | Phase 2 |
Why NCT00966823 stopped before completion
NCT00966823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Fetal tracheal obstruction with detachable balloon (device) is the first listed.
NCT00966823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00966823 about?
NCT00966823 is a clinical study titled "Fetal Tracheal Balloon Study in Diaphragmatic Hernia". The purpose of this phase 2 limited study is to examine whether prenatal intervention correct the lung underdevelopment associated with severe diaphragmatic hernia.
What is the current status of trial NCT00966823?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2008-09. Estimated completion is 2015-01.
What interventions are being tested in trial NCT00966823?
The interventions under investigation include: Fetal tracheal obstruction with detachable balloon (device) (DEVICE).
Who is sponsoring clinical trial NCT00966823?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00966823's enrollment target sits among peer trials
3 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia